Navigation Links
Good news for the medical marijuana movement: pot proliferates brain cells and boosts mood

Most drugs of abuse decrease the generation of new neurons in the brain, but the effects of marijuana on this process, called neurogenesis, had not been clear.

In a paper appearing online on October 13 in advance of print publication of the November issue of the Journal of Clinical Investigation, Xia Zhang and colleagues from University of Saskatchewan show that a potent and synthetic cannabinoid promotes neurogenesis. This drug also exerts anti-anxiety and antidepressant-like effects.

The researchers suggest that there is a positive correlation between increased adult neurogenesis and modified behavior following chronic cannabinoid treatment. These data expand the existing knowledge about the positive roles cannabinoids and their receptors play in brain processing and medicine. Moreover, cannabinoids are perhaps the only illicit drug that can enhance adult neurogenesis and subsequently modify behavior.


'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. Automatic extraction of gene/protein biological functions from biomedical text
2. Vital step in cellular migration described by UCSD medical researchers
3. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
4. UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints
5. Innovative coating could give medical implants a longer life
6. Natural tumor suppressor in body discovered by UCSD medical researchers
7. Protein synthesis can be controlled by light, opening way for new scientific, medical applications
8. Modified collagen could yield important medical applications
9. UCSD discovery may provide novel method to generate medically useful proteins
10. Scientists create digital bacteria to forge advances in biomedical research
11. European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... 2020 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical investigator ... career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and anti-infective ...
(Date:8/5/2020)... ... 2020 , ... Regenative Labs has received approval from the Centers for Medicare ... the first Wharton’s jelly allografts to be assigned a Q code and be approved ... first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS ...
(Date:7/18/2020)... SAN ANTONIO (PRWEB) , ... July 16, 2020 ... ... PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise ... (NICU) environment. The study reported that the Neoasis™ device attenuated the alarm sounds ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... the top radiation centers in 16 countries, has reached its 20th anniversary of ... now in routine use at top universities including University of Pennsylvania, University of ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... aid in the early detection and prevention of high-burden diseases, and Centric Consulting, ... hospitals and healthcare organizations to utilize existing data in order to identify and ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
Breaking Biology Technology: